Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Agammaglobulinemia × Hizentra × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myasthenia Gravis 4 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Common Variable Immunodeficiency 1 Agammaglobulinemia 1

Interventions

ofatumumab 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Lenalidomide 1 Immunoglobulins 1 Hizentra 1 Clavulanic Acid 1 Ciprofloxacin 1 Amoxicillin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06976476 2026-03-11

Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting

Agammaglobulinemia, Multiple Myeloma, Common Variable Immunodeficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡